Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "We all have AIDS": case for reducing the cost of HIV drugs to zero.

Literature DB >> 11809645

"We all have AIDS": case for reducing the cost of HIV drugs to zero.

Donald Berwick¹.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-HIV Agents

Year: 2002 PMID： 11809645 PMCID： PMC1122133 DOI： 10.1136/bmj.324.7331.214

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

9 in total

1. Clouding the AIDS issue

Authors:
Journal: BMJ Date: 2000-04-08

2. US trade action threatens Brazilian AIDS programme.

Authors: G Yamey
Journal: BMJ Date: 2001-02-17

3. Community-based approaches to HIV treatment in resource-poor settings.

Authors: P Farmer; F Léandre; J S Mukherjee; M Claude; P Nevil; M C Smith-Fawzi; S P Koenig; A Castro; M C Becerra; J Sachs; A Attaran; J Y Kim
Journal: Lancet Date: 2001-08-04 Impact factor: 79.321

4. Public health. Responding to market failures in tuberculosis control.

Authors: R Gupta; J Y Kim; M A Espinal; J M Caudron; B Pecoul; P E Farmer; M C Raviglione
Journal: Science Date: 2001-07-19 Impact factor: 47.728

5. Kofi Annan describes new health fund for developing countries.

Authors: P Brown
Journal: BMJ Date: 2001-05-26

6. AIDS epidemic update: December 1999.

Authors:
Journal: AIDS Anal Afr Date: 2000 Feb-Mar

Review 7. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Authors: P Farmer; J Y Kim
Journal: BMJ Date: 1998-09-05

8. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245

9. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors: A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal: Lancet Date: 1998-11-28 Impact factor: 79.321

9 in total

5 in total

"We all have AIDS": case for reducing the cost of HIV drugs to zero.

1. Clouding the AIDS issue

2. US trade action threatens Brazilian AIDS programme.

3. Community-based approaches to HIV treatment in resource-poor settings.

4. Public health. Responding to market failures in tuberculosis control.

5. Kofi Annan describes new health fund for developing countries.

6. AIDS epidemic update: December 1999.

Review 7. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

8. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

9. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1. AIDS and global justice.

2. New strategies in the delivery of HIV-prevention services for minority groups in the U.S.

3. Market power and state costs of HIV/AIDS drugs.

4. Access to antiretroviral therapy among HIV/AIDS patients in Chiang Mai province, Thailand.

5. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth.